FI56772C - Foerfarande foer framstaellning av en beredning foer behandling av onormala tarmtillstaond - Google Patents

Foerfarande foer framstaellning av en beredning foer behandling av onormala tarmtillstaond Download PDF

Info

Publication number
FI56772C
FI56772C FI760948A FI760948A FI56772C FI 56772 C FI56772 C FI 56772C FI 760948 A FI760948 A FI 760948A FI 760948 A FI760948 A FI 760948A FI 56772 C FI56772 C FI 56772C
Authority
FI
Finland
Prior art keywords
preparation
colon
foer
tarmtillstaond
onormala
Prior art date
Application number
FI760948A
Other languages
English (en)
Finnish (fi)
Other versions
FI760948A (fr
FI56772B (fi
Inventor
Curt Henry Appelgren
Conny Boerje Bogentoft
John Albert Sjoegren
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of FI760948A publication Critical patent/FI760948A/fi
Publication of FI56772B publication Critical patent/FI56772B/fi
Application granted granted Critical
Publication of FI56772C publication Critical patent/FI56772C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/78Polymers containing oxygen of acrylic acid or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
FI760948A 1975-04-09 1976-04-07 Foerfarande foer framstaellning av en beredning foer behandling av onormala tarmtillstaond FI56772C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE7504049 1975-04-09
SE7504049A SE7504049L (sv) 1975-04-09 1975-04-09 Colonpreparation

Publications (3)

Publication Number Publication Date
FI760948A FI760948A (fr) 1976-10-10
FI56772B FI56772B (fi) 1979-12-31
FI56772C true FI56772C (fi) 1980-04-10

Family

ID=20324216

Family Applications (1)

Application Number Title Priority Date Filing Date
FI760948A FI56772C (fi) 1975-04-09 1976-04-07 Foerfarande foer framstaellning av en beredning foer behandling av onormala tarmtillstaond

Country Status (12)

Country Link
BE (1) BE840552A (fr)
DE (1) DE2614296A1 (fr)
DK (1) DK153376A (fr)
FI (1) FI56772C (fr)
FR (1) FR2306710A1 (fr)
GB (1) GB1538123A (fr)
IE (1) IE42793B1 (fr)
LU (1) LU74732A1 (fr)
NL (1) NL7603600A (fr)
NO (1) NO761101L (fr)
NZ (1) NZ180552A (fr)
SE (1) SE7504049L (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52139715A (en) * 1976-05-14 1977-11-21 Nippon Kayaku Co Ltd Coated granules of alkali polyacrylate
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
US4444761A (en) * 1981-05-04 1984-04-24 Syntex (U.S.A.) Inc. Cellulose/carboxymethyl cellulose mixtures useful for controlling fecal output, and methods employing them
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
US4522804A (en) * 1983-01-03 1985-06-11 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of propranolol
US4521401A (en) * 1983-01-03 1985-06-04 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of quinidine
EP0273209B1 (fr) * 1986-12-30 1992-01-15 American Cyanamid Company Composition contenant un polycarbophile
GB8817015D0 (en) * 1988-07-16 1988-08-17 Reckitt & Colmann Prod Ltd Method of treatment
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
CA2082156A1 (fr) * 1990-05-04 1991-11-05 Amnon Sintov Systeme permettant l'administration d'un medicament dans le colon
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
DE9212938U1 (fr) * 1992-09-25 1992-11-26 Boehringer Ingelheim Gmbh, 6507 Ingelheim, De
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
WO2018191752A1 (fr) 2017-04-14 2018-10-18 Gelesis Llc Compositions et méthodes pour le traitement ou la prévention de troubles liés à la perméabilité intestinale

Also Published As

Publication number Publication date
GB1538123A (en) 1979-01-10
DE2614296A1 (de) 1976-10-21
FR2306710A1 (fr) 1976-11-05
NO761101L (fr) 1976-10-12
DK153376A (da) 1976-10-10
FI760948A (fr) 1976-10-10
FI56772B (fi) 1979-12-31
SE7504049L (sv) 1976-10-10
IE42793L (en) 1976-10-09
NZ180552A (en) 1978-07-28
IE42793B1 (en) 1980-10-22
NL7603600A (nl) 1976-10-12
FR2306710B1 (fr) 1979-07-13
LU74732A1 (fr) 1977-02-04
BE840552A (fr) 1976-10-11

Similar Documents

Publication Publication Date Title
FI56772C (fi) Foerfarande foer framstaellning av en beredning foer behandling av onormala tarmtillstaond
US4511561A (en) Laxative composition comprising psyllium seeds and senna fruits
US4470975A (en) Method and composition for the elimination of water from an animal body
CN106750398A (zh) 载药壳聚糖/海藻酸钠双重交联水凝胶及其制法和应用
Madgulkar et al. Characterization of psyllium (Plantago ovata) polysaccharide and its uses
DE60026459T2 (de) Simethicon enthaltendes Abführmittel
CN101091700B (zh) 富马酸喹硫平缓控释制剂组合物及其制备用途
US11213559B2 (en) Formulation for treatment of irritable bowel disease
FI75095B (fi) Foerfarande foer framstaellning avfoeringsmedel baserat pao ratamonfroen och sennafrukter.
CN108938601B (zh) 一种盐酸二甲双胍肠溶缓释微丸及其制备方法
WO2005074952A1 (fr) Medicament chinois pour le traitement du syndrome du colon irritable ainsi que preparation de celui-ci
CN101491493A (zh) 阿魏酸哌嗪缓释药物制剂
CN1895520B (zh) 一种胃铋镁颗粒及其制备方法
CN109999117A (zh) 防治肠炎、菌痢、痢疾、顽固性腹泻的中药组合物
RU2559590C2 (ru) Применение полисахаридов для лечения стресса и тревоги
US4652446A (en) Pharmaceutical compositions
WO1996031239A1 (fr) 5omposition pharmaceutique renfermant de la pectine et un phospholipide, et servant d'agent anti-diarrheique et anti-ulcereux
CN102716128A (zh) 一种治疗哮喘的药用组合物
US2990327A (en) Composition and method for treating biliary dyskinesia
Marks Cellulose esters in the treatment of constipation
CN117481345B (zh) 一种具有肠胃调节功能的壳寡糖组合物及功能糖
KR100849806B1 (ko) 팽윤성 식이섬유와 리파제 억제제를 포함하는 비만 억제조성물 및 이의 제조 방법
CN107137491A (zh) 一种治疗甲状腺肿大的药物组合物及其制备方法
CN105853419B (zh) 一种用于胃溃疡治疗的药物组合物及其应用
CN103565748B (zh) 一种聚乙二醇4000散剂

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: AB HAESSLE